首页> 外文学位 >Magnetic drug targeting: Development of a novel drug delivery system for prostate cancer therapy.
【24h】

Magnetic drug targeting: Development of a novel drug delivery system for prostate cancer therapy.

机译:磁性药物靶向:开发用于前列腺癌治疗的新型药物递送系统。

获取原文
获取原文并翻译 | 示例

摘要

Magnetic nanoparticles (MNPs) have been attracting a great amount of attention because of their numerous applications including contrast agents in magnetic resonance imaging (MRI), magnetic targeted drug carriers, and hyperthermia treatments for cancer. However, complications, including aggregation of MNPs, have limited their use in drug delivery applications. To overcome these limitations, several methods have been developed to coat magnetic particles. One method includes coating them with polymers to produce polymer/MNPs for increasing the MNP dispersion and stability. This method also increases the efficiency of loading and releasing drugs to specific locations for the treatment of various diseases including prostate cancer.;The major objective of this research project was to develop polymer magnetic nanoparticles (PMNPs) using a silane coupling agent and a novel thermo-sensitive polymer, N-isopropylacrylamide-acrylamide-allylamine (NIPA-AAm-AH). The temperature-sensitive polymers were chosen as a shell for the purpose of creating a controlled drug delivery system. In this system, the temperature induced by the magnetic core would be used to release therapeutic agents from the polymer shell at a specific location. The chemical and physical properties of these PMNPs were determined using Fourier transformed infrared spectroscopy, nuclear magnetic resonance, x-ray photoelectron spectroscopy, and a superconducting quantum interference device. Transmission electron microscopy indicated the size of our PMNPs were about 100 nm. These nanoparticles had a better biocompatibility in comparison to the original MNPs using cytotoxicity assays (e.g. MTS assays). Moreover, bovine serum albumin (BSA) and doxorubicin release profiles from the nanoparticles indicated that our PMNPs released drugs in response to changes in temperature. Finally, results from iron assays and parallel flow chamber systems, with external magnets used to assess the cellular uptake and in vitro localization of the synthesized nanoparticles, indicated that these nanoparticles would provide a means for magnet targeting capabilities.
机译:磁性纳米颗粒(MNP)由于其众多应用而引起了广泛的关注,包括磁共振成像(MRI)中的造影剂,磁性靶向药物载体和癌症的高热治疗。但是,包括MNP聚集在内的并发症限制了它们在药物递送应用中的使用。为了克服这些限制,已经开发了几种涂覆磁性颗粒的方法。一种方法包括用聚合物涂覆它们以产生聚合物/ MNP,以增加MNP的分散性和稳定性。这种方法还提高了将药物装载和释放到特定位置的效率,以治疗包括前列腺癌在内的各种疾病。该研究项目的主要目标是使用硅烷偶联剂和新型热敏聚合物开发聚合物磁性纳米颗粒(PMNP)。敏感聚合物,N-异丙基丙烯酰胺-丙烯酰胺-烯丙胺(NIPA-AAm-AH)。选择温度敏感的聚合物作为壳,以产生受控的药物递送系统。在该系统中,由磁芯感应的温度将用于从特定位置的聚合物外壳释放治疗剂。使用傅立叶变换红外光谱,核磁共振,X射线光电子能谱和超导量子干涉仪测定了这些PMNP的化学和物理性质。透射电子显微镜表明,我们的PMNP的大小约为100 nm。与使用细胞毒性测定法(例如MTS测定法)的原始MNP相比,这些纳米粒子具有更好的生物相容性。此外,牛纳米颗粒的牛血清白蛋白(BSA)和阿霉素的释放曲线表明,我们的PMNPs随温度变化释放药物。最后,铁测定和平行流室系统的结果以及使用外部磁体评估合成纳米颗粒的细胞吸收和体外定位结果表明,这些纳米颗粒将为磁体靶向能力提供一种手段。

著录项

  • 作者

    Rahimi, Maham.;

  • 作者单位

    The University of Texas at Arlington.;

  • 授予单位 The University of Texas at Arlington.;
  • 学科 Engineering Biomedical.
  • 学位 Ph.D.
  • 年度 2008
  • 页码 132 p.
  • 总页数 132
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物医学工程;
  • 关键词

  • 入库时间 2022-08-17 11:38:58

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号